ACG Engineering (ACGE), part of ACG Group, a supplier of end-to end manufacturing solutions for the pharmaceutical industry, has recently announced acquisition of Xertecs GmbH, a German pharma processing equipment company. ACG acquired 100 per cent shareholding that comes following a long partnership between the two entities.

The acquisition provides a strong injection of European design into ACGE’s capabilities roster, as the Xertecs facility and team in Muellheim, Germany becomes a key ‘Centre of Excellence’ to serve as ACG Innovation Centre Europe. The acquisition aims to give customers the best of both continents. It will comprise of sophisticated European design combined with Indian value centric engineering and manufacturing.

Xertecs develops and implements processes, products and services for pharma companies around the world. Its portfolio includes conceptualisation; design engineering; prototype development; automation design and integration into MES systems; development and optimization of components; complete plant design including 3D modeling; process optimization and delivery of new process equipment.

Richard Stedman, Group CEO, ACG Engineering, said, “This is a tremendous boost for our commitment to create next-generation machines that serve our pharmaceutical and nutraceutical customers. The Xertecs team brings best-in-class design and product management skills to ACG Engineering. We are looking forward to developing a wide range of innovative, ground-breaking equipment solutions and best-practice initiatives between the two teams.”

Klaus Groeschel, MD-Sales & Marketing, Xertecs stated, “This represents a great opportunity for ACG to meet global design standards throughout its product portfolio. This is the next logical step in the relationship between our two businesses. The team at Xertecs is very enthusiastic for the opportunity to continue contributing to ACG’s global product offerings and service capabilities.”